Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
7,250.00
-170.00 (-2.29%)
At close: May 20, 2026
116.42% (1Y)
| Market Cap | 205.37B +117.6% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 122.97 |
| Forward PE | n/a |
| Dividend | 30.00 (0.39%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 268,819 |
| Average Volume | 514,928 |
| Open | 7,160.00 |
| Previous Close | 7,420.00 |
| Day's Range | 7,090.00 - 7,410.00 |
| 52-Week Range | 3,285.00 - 15,960.00 |
| Beta | 0.84 |
| RSI | 33.23 |
| Earnings Date | n/a |